These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Improved griseofulvin therapy for tinea pedis. Altman D J Am Podiatry Assoc; 1966 Jan; 56(1):15-7. PubMed ID: 4221780 [No Abstract] [Full Text] [Related]
23. [Thearpy of tinea unguium and results of follow-up examinations since the introduction of griseofulvin]. Nolting S; Fegeler K; Ludwig G; Plischewski K Mykosen; 1975 Jan; 18(1):11-5. PubMed ID: 123314 [No Abstract] [Full Text] [Related]
24. Systemic antifungal therapy for cutaneous infections in children. Sethi A; Antaya R Pediatr Infect Dis J; 2006 Jul; 25(7):643-4. PubMed ID: 16804437 [No Abstract] [Full Text] [Related]
25. Treatment of onychomycosis in a foot clinic. Jaskoski BJ; Kasdan PR J Am Podiatry Assoc; 1969 Jun; 59(6):230-3. PubMed ID: 4240223 [No Abstract] [Full Text] [Related]
26. [On the therapy of nail trichophytosis]. Sowiński W Mykosen; 1967 Oct; 10(10):453-8. PubMed ID: 4234714 [No Abstract] [Full Text] [Related]
27. [Treatment of mycoses in patients with circulatory disorders of the lower limbs]. Eletskaia LV Vestn Khir Im I I Grek; 1974 Jul; 113(7):47-50. PubMed ID: 4277959 [No Abstract] [Full Text] [Related]
28. [The antifungal antibiotic griseofulvin in the treatment of onychomycosis]. Ashmarin IuIa; Burov GP Voen Med Zh; 1967 Aug; 8():74-7. PubMed ID: 4236381 [No Abstract] [Full Text] [Related]
29. [Treatment of onychomycoses]. Golod MS Vestn Dermatol Venerol; 1977 Jan; (1):72-4. PubMed ID: 139787 [No Abstract] [Full Text] [Related]
31. [Continuous or discontinuous therapy of onychomycoses with resorption-active griseofulvin?]. Seebacher C Mykosen; 1966 Sep; 9(3):126-9. PubMed ID: 4224979 [No Abstract] [Full Text] [Related]
32. [Methods of control in treatment of patients with systemic onychomycosis with griseofulvin]. Zaboikina VA Vestn Dermatol Venerol; 1968 Jun; 42(6):40-4. PubMed ID: 4247789 [No Abstract] [Full Text] [Related]
33. Onychomycosis treated with ultrafine griseofulvin. Quintavalle P J Am Podiatry Assoc; 1966 Mar; 56(3):119-20. PubMed ID: 4222118 [No Abstract] [Full Text] [Related]
34. [Onychomycosis: experiences with atraumatic nail avulsion]. Dorn M; Kienitz T; Ryckmanns F Hautarzt; 1980 Jan; 31(1):30-4. PubMed ID: 6446529 [TBL] [Abstract][Full Text] [Related]
35. Onychomycosis. Agents of choice. Hay RJ Dermatol Clin; 1993 Jan; 11(1):161-9. PubMed ID: 8382121 [TBL] [Abstract][Full Text] [Related]
37. The future of onychomycosis therapy may involve a combination of approaches. Hay RJ Br J Dermatol; 2001 Oct; 145 Suppl 60():3-8. PubMed ID: 11777262 [TBL] [Abstract][Full Text] [Related]
38. A cost/efficacy analysis of oral antifungals indicated for the treatment of onychomycosis: griseofulvin, itraconazole, and terbinafine. Angello JT; Voytovich RM; Jan SA Am J Manag Care; 1997 Mar; 3(3):443-50. PubMed ID: 10173095 [TBL] [Abstract][Full Text] [Related]
39. The systemic treatment of onychomycosis. Wenig JA Clin Podiatr Med Surg; 1995 Apr; 12(2):263-74. PubMed ID: 7600500 [TBL] [Abstract][Full Text] [Related]